Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community.

被引：0
|
作者：
Patt, D. A.
Espirito, J. L.
Turnwald, B.
Hoverman, J. R.
Neubauer, M. A.
Busby, L. T.
Broolos, B. D.
Kolodziej, M. A.
Anderson, R. W.
Beveridge, R. A.
机构：
[1] US Oncol, The Woodlands, TX USA
[2] US Oncol, Texas Oncol, The Woodlands, TX USA
[3] US Oncol, Kansas City Canc Ctr, The Woodlands, TX USA
[4] US Oncol, Rocky Mt Canc Ctr, Boulder, CO USA
[5] US Oncol, New York Hematol Oncol, Albany, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 27期
关键词：
D O I：
10.1200/jco.2011.29.27_suppl.213
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
213
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Primary and Secondary Pegfilgrastim Utilization in Adjuvant Chemotherapy for Breast Cancer in the Community.
    Patt, D. A.
    Espirito, J. L.
    Turnwald, B.
    Hoverman, J. R.
    Neubauer, M. A.
    Busby, L. T.
    Brooks, B. D.
    Kolodziej, M. A.
    Anderson, R. W.
    Beveridge, R. A.
    [J]. CANCER RESEARCH, 2011, 71
  • [2] Utilization and relative value of breast cancer adjuvant chemotherapy regimens in the community
    Patt, D. A.
    Espirito, J. L.
    Turnwald, B.
    Hoverman, J. R.
    Neubauer, M. A.
    Cartwright, T. H.
    Brooks, B. D.
    Busby, L. T.
    Sitarik, M. A.
    Kolodziej, M. A.
    Ginsburg, A. L.
    Sheth, S.
    Garey, J. S.
    Clayton, M.
    Nelson, G. C.
    Anderson, R. W.
    Beveridge, R. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Different adjuvant chemotherapy regimens in older breast cancer patients?
    Wildiers, H.
    Brain, E.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 (04) : 613 - 615
  • [4] Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support
    Wolff, AC
    Jones, RJ
    Davidson, NE
    Jeter, SC
    Stearns, V
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2392 - 2394
  • [5] Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support - Reply
    Burstein, Harold J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) : 2394 - 2395
  • [6] Tailoring adjuvant chemotherapy regimens for patients with triple negative breast cancer
    Stover, Daniel G.
    Winer, Eric P.
    [J]. BREAST, 2015, 24 : S132 - S135
  • [7] Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens
    Leal, Alexis D.
    Van Houten, Hay
    Sangaralingham, Lindsey
    Freedman, Rachel A.
    Jemal, Ahmedin
    Neuman, Heather B.
    Haddad, Tufia C.
    Mutter, Robert W.
    Keegan, Theresa H. M.
    Mougalian, Sarah S.
    Loprinzi, Charles L.
    Gross, Cary P.
    Shah, Nilay
    Ruddy, Kathryn J.
    [J]. CLINICAL BREAST CANCER, 2018, 18 (04) : E513 - E520
  • [8] Weight change during adjuvant chemotherapy regimens for breast cancer.
    Speck, R. M.
    DeMichele, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens
    Griggs, Jennifer J.
    Culakova, Eva
    Sorbero, Melony E. S.
    Poniewierski, Marek S.
    Wolff, Debra A.
    Crawford, Jeffrey
    Dale, David C.
    Lyman, Gary H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18) : 2522 - 2527
  • [10] Aortitis and aortic dissection after administration of pegfilgrastim during adjuvant chemotherapy for early breast cancer
    Shiraki, Eriko
    Hamada-Nishimoto, Mai
    Kang, Yookija
    Tsuyuki, Shigeru
    [J]. INTERNATIONAL CANCER CONFERENCE JOURNAL, 2022, 11 (02) : 138 - 141
12345